This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Abbott (company) | |
|---|---|
| Name | Abbott Laboratories |
| Type | Public |
| Founded | 1888 |
| Founder | Wallace Calvin Abbott |
| Headquarters | North Chicago, Illinois |
| Area served | Worldwide |
| Key people | Robert B. Ford, Jorge Conde |
| Industry | Healthcare |
| Products | Pharmaceuticals, medical devices, diagnostics, nutritional products |
| Revenue | US$ 41.5 billion (2023) |
| Num employees | 113,000 (2023) |
| Website | www.abbott.com |
Abbott (company) Abbott is a global healthcare company that develops pharmaceuticals, medical devices, in vitro diagnostics and nutritional products. Founded in 1888 by Wallace Calvin Abbott in Chicago, it is headquartered in North Chicago, Illinois and operates across the United States, Europe, Asia, Africa, and Latin America. The company is listed on the New York Stock Exchange and is a component of the S&P 500 index and the Fortune 500.
Abbott was founded in 1888 by Wallace Calvin Abbott after developing a powdered medicine based on extracts used in physician practice in Chicago. The firm expanded through the early 20th century with research ties to institutions such as the Johns Hopkins Hospital and collaborations that paralleled developments at Parke-Davis and Eli Lilly and Company. During the mid-20th century Abbott diversified into diagnostics and nutrition amid industry consolidation involving companies like Bristol-Myers Squibb and Merck & Co.. In the 1990s and 2000s Abbott pursued acquisitions including Kendall Company and MediSense, and in 2013 executed a major corporate restructuring that split Abbott Laboratories into separate entities alongside AbbVie. Subsequent acquisitions included Alere in 2017 and St. Jude Medical in 2017, expanding its footprint in point-of-care testing and cardiovascular devices. In the 2020s Abbott furthered growth with products such as the BinaxNOW COVID-19 antigen test and the FreeStyle Libre continuous glucose monitoring system, reflecting ties to pandemic response efforts alongside peers like Roche and Siemens Healthineers.
Abbott is a publicly traded company incorporated in the United States and governed by a board of directors that includes executives and independent members with backgrounds at firms such as Johnson & Johnson, Pfizer, Intel Corporation, and McKinsey & Company. The company’s executive leadership has included CEOs who engage with regulators like the U.S. Food and Drug Administration and agencies including the European Medicines Agency and Health Canada. Abbott maintains investor relations activities with institutional holders such as BlackRock, The Vanguard Group, and State Street Corporation, and files financial reports with the U.S. Securities and Exchange Commission.
Abbott’s principal divisions encompass pharmaceuticals, medical devices, diagnostics, and nutrition. In pharmaceuticals the company markets branded therapies in fields overlapping with oncology and cardiology; in devices it produces stents and structural heart products competing with Medtronic and Boston Scientific. Its diagnostics portfolio includes molecular, immunoassay, and point-of-care platforms such as systems rivaling Thermo Fisher Scientific and Qiagen. Nutritional products include infant formula and adult nutritionals in categories alongside Nestlé and Danone. Flagship products include the FreeStyle Libre CGM system for diabetes management, vascular devices derived from the St. Jude Medical acquisition, and rapid diagnostics like the BinaxNOW test used during the COVID-19 pandemic.
Abbott operates R&D centers and collaborates with academic institutions including Massachusetts Institute of Technology, University of California, San Francisco, and Imperial College London. R&D efforts span medical device engineering, biomarker discovery, and point-of-care diagnostics, often involving partnership models with startups and investors such as Sequoia Capital and technology firms like Google and Apple in digital health initiatives. Abbott files patents with the United States Patent and Trademark Office and pursues clinical trials registered with ClinicalTrials.gov and reviewed by institutional review boards affiliated with hospitals including Mayo Clinic and Cleveland Clinic.
Abbott reports revenues, net income, and segment results in quarterly filings to the U.S. Securities and Exchange Commission. The company’s revenue mix reflects strong contributions from diagnostics and medical devices, with market competition from Roche, AbbVie, and Johnson & Johnson. Institutional investors and analysts from firms such as Goldman Sachs and Morgan Stanley cover Abbott’s equity, and credit ratings are provided by agencies including Moody's Investors Service and Standard & Poor's.
Abbott engages in global health initiatives with organizations like the World Health Organization, United Nations Children's Fund, and Doctors Without Borders through product donations and capacity-building programs. The company publishes sustainability reports aligned with frameworks such as the Global Reporting Initiative and participates in access-to-medicine efforts coordinated with the Access to Medicine Foundation. Abbott also adheres to compliance programs and codes of conduct enforced through internal audit and oversight, and interacts with ethics bodies like the Office of Inspector General (United States Department of Health and Human Services) when relevant.
Abbott has faced litigation and regulatory scrutiny related to product safety, marketing practices, and patent disputes involving competitors such as Medtronic and Boston Scientific. High-profile matters include recalls and investigations tied to medical devices and infant nutrition products during major public health events like the COVID-19 pandemic. The company has engaged in settlement agreements and contested cases before courts including the United States District Court for the Northern District of Illinois and arbitration panels, and has negotiated resolutions with entities such as the U.S. Department of Justice and state attorneys general.
Category:Medical technology companies Category:Multinational companies headquartered in the United States